25-Hydroxyvitamin D (25OHD), Serum 

Synonym 25-Hydroxycalciferol
Specimen requirement Adult patient:

  Clotted blood tube (Serum gel separator clot activator tube)

Minimum blood volume: 5 mL

Paediatric patient:

Paediatric clotted blood tube

Number of vials: 1

Minimum blood volume: 0.8 mL

Authorisation code required Yes
24 Hr available service No
Precaution

Blood sample should be collected before starting vitamin D supplement unless there is doubt whether the vitamin is being absorbed.

A fasting specimen is recommended.

Method Liquid chromatography-tandem mass spectrometry
Reference interval

Total 25OH Vitamin D:

< 12.5 nmol/L Severe deficiency
12.5 - 29 nmol/L Moderate deficiency
30 - 49 nmol/L Mild deficiency
50 - 220 nmol/L Sufficient
> 220 nmol/L Potentially toxic

 

(Source:

1. Med J Aust 2012; 196 (11): 686 - 7

2. Med J Aust 2013; 198 (3): 142 - 3)

Clinical indication Investigation of patients with obscure hyper- or hypo-calcaemia.

Investigation of suspected rickets and osteomalacia (e.g. malabsorption, dietary deficiency).

Investigation of suspected vitamin D toxicity (e.g. hypercalcaemia, nephrocalcinosis, overdose).

Result interpretation

Serum total 25-hydroxyvitamin D (25OHD) concentration, mainly the sum of serum 25-hydroxyvitamin D2 and D3 concentrations, is used to evaluate vitamin D status. The biologically active forms of the hormone are 1,25-dihydroxyvitamin Ds which regulate calcium and phosphorous homeostasis. Although 25OHD is usually reliable for the diagnosis of abnormal vitamin D status, in a few instances (e.g. sarcoidosis, oncogenic osteomalacia), 1,25-dihydroxyvitamin D alone is abnormal.

Measurement of uncertainty See table.
Frequency of measurement 2 weeks